Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Genet Med. 2023 Jul 6;25(10):100926. doi: 10.1016/j.gim.2023.100926

Figure 1: Variation in approval for genetic testing across level IV NICUs.

Figure 1:

Variation in approval processes (A), types of specialists providing approval for testing (B), and insurance processes (C) is displayed. CMA, chromosomal microarray; ES, exome sequencing; GS, genome sequencing.